Liquidia (LQDA) EV to Revenue (2019 - 2026)

Liquidia (LQDA) EV to Revenue (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EV to Revenue
1 Teva Pharmaceutical Industries 36.44 Bn 32.71 Bn 1.97 Bn 1.89
2 Zoetis 33.18 Bn 31.24 Bn 1.62 Bn 3.29
3 United Therapeutics 23.36 Bn 21.20 Bn 648.10 Mn 6.69
4 Neurocrine Biosciences 15.90 Bn 14.58 Bn 800.70 Mn 4.70
5 Aurora Cannabis 15.07 Bn 14.99 Bn 21.72 Mn 64.70
6 Elanco Animal Health 12.06 Bn 11.63 Bn 785.00 Mn 2.38
7 Hims & Hers Health 8.09 Bn 7.34 Bn 396.79 Mn 3.10
8 Alkermes 7.47 Bn 6.96 Bn -116.06 Mn 5.75
9 Lantheus Holdings 6.69 Bn 6.19 Bn 230.92 Mn 4.00
10 Liquidia 6.26 Bn 6.03 Bn 121.79 Mn 20.95

Historic Data

Download Data
DateValue
Jun 18, 2026 20.95
Jun 17, 2026 20.16
Jun 16, 2026 19.85
Jun 15, 2026 21.14
Jun 12, 2026 20.98
Jun 11, 2026 21.19
Jun 10, 2026 19.16
Jun 9, 2026 18.81
Jun 8, 2026 18.76
Jun 5, 2026 18.12
Jun 4, 2026 18.33
Jun 3, 2026 16.24
Jun 2, 2026 16.04
Jun 1, 2026 17.32
May 29, 2026 18.13
May 28, 2026 18.18
May 27, 2026 18.18
May 26, 2026 17.64
May 22, 2026 17.86
May 21, 2026 18.19